Synopsis: Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reduced risk of disease progression or death by 50% and…
AstraZeneca
-
-
AstraZenecaMerger / Acquisition
AstraZeneca to Acquire TeneoTwo and its Clinical-stage T-cell Engager TNB-486
by adminby adminSummary : AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under…
-
AstraZenecaCompaniesMerck & CoRegulatoryU.S FDA
AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy
by adminby adminSummary : The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending…
-
AstraZenecaRegulatoryU.S FDA
FDA says no to AZ’s Fasenra for nasal polyp indication
by adminby adminSummary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
-
AstraZenecaPharma Science & Research
First RSV vaccine trial for infants offers significant results
by adminby adminSummary : Results from a phase 3 trial evaluating AstraZeneca and Sanofi’s jointly developed treatment nirsevimab – the first investigational long-acting antibody, designed to protect…
-
AstraZenecaCovid DrugsRegulatoryU.S FDA
FDA Adjusts EUA Dosing On Evusheld To Fight Omicron
by adminby adminSummary: The U.S. Food and Drug Administration (FDA) has revised its emergency use authorization (EUA) for AstraZeneca’s Evusheld to a higher dose…
-
AstraZenecaCompaniesGlobal MarketPharma Science & Research
AstraZeneca in the News: EMA Greenlights RSV Vaccine, Leif Johansson Departing
by adminby adminSummary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was…
-
AstraZenecaIndia
Glenmark inks pact to commercialise AstraZeneca’s asthma drug in Colombian market
by adminby adminSummary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the…
-
AgrochemicalsAstraZenecaGlobal Market
AstraZeneca sells another half-million doses of its COVID-19 antibody combo to the US
by adminby adminSummary : Order up. Shortly after topping off supplies of COVID-19 drugs from Pfizer and GlaxoSmithKline, the U.S. has asked for a…
-
AstraZenecaPharma Science & Research
New study finds AstraZeneca booster generates higher antibodies against Omicron
by adminby adminSummary : AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from…